Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
GSK
Stock Latest News
The Fly
Trump Weekly: Trump weighs stake in Intel, candidates for Fed Chair
8d ago
AMD
AZN
Premium
Company Announcements
GSK and iTeos Advance Immunotherapy Study for Lung Cancer
8d ago
GSK
ITOS
Premium
The Fly
Trump Trade: Pharma tariff announcement likely ‘weeks away’
9d ago
AZN
BMY
Premium
The Fly
Pharma tariff announcement likely ‘weeks away,’ Reuters reports
10d ago
AZN
BMY
Premium
The Fly
GSK announces FDA accepted for priority review supplemental NDA for gepotidacin
12d ago
GSK
Premium
The Fly
Sector Spotlight: Trump administration seeks hometown discount from Big Pharma
15d ago
AZN
BMY
Premium
Company Announcements
GSK and Ideaya’s Promising Study on Solid Tumors: A Potential Game-Changer?
15d ago
GSK
IDYA
Premium
Company Announcements
GSK’s New Study on Multiple Myeloma Treatment: What Investors Need to Know
15d ago
GSK
Premium
Company Announcements
GSK’s Promising Study on Belimumab for Lung Disease: What Investors Need to Know
15d ago
GSK
Premium
Company Announcements
GSK and iTeos Therapeutics’ Promising Phase 3 Lung Cancer Study: Market Implications
15d ago
GSK
ITOS
Premium
Company Announcements
GSK’s Phase 3 Study on Dostarlimab: A Potential Game-Changer in Colon Cancer Treatment?
15d ago
GSK
Premium
Company Announcements
GSK’s RSV Vaccine Study: A Potential Game-Changer for Older Adults
15d ago
GSK
Premium
Company Announcements
GSK’s Phase 3 RSV Vaccine Study: Key Insights for Investors
15d ago
GSK
Premium
Company Announcements
GSK’s RSV Vaccine Study: A Potential Game-Changer for Transplant Recipients
15d ago
GSK
Premium
The Fly
Trump, pharma industry discuss increasing medicine spending abroad, Reuters says
15d ago
AZN
BMY
Premium
The Fly
GSK provides update on U.S. settlement CureVac/BioNTech mRNA patent litigation
15d ago
GSK
PFE
Premium
Company Announcements
GSK’s New Study on GSK5764227: A Potential Game-Changer in Gastrointestinal Cancer Treatment
16d ago
GSK
Premium
Company Announcements
GSK’s MenABCWY Vaccine Study: A Potential Game-Changer in Meningococcal Disease Prevention
16d ago
GSK
Premium
Company Announcements
GSK’s POPSTAR Study: A New Hope in Pediatric Cancer Treatment
16d ago
GSK
Premium
Company Announcements
GSK’s RSV Vaccine Study: Key Insights for Investors
16d ago
GSK
Premium
Company Announcements
GSK’s New Clinical Study on Endometrial Cancer: What Investors Need to Know
16d ago
GSK
Premium
Company Announcements
GSK Completes Promising Study on Gonorrhea Vaccine
16d ago
GSK
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
